As investors it's hard to let go sometimes. It's time to accept that rem-l as a treatment in any way shape or form to treat covid isn't going to happen. No EUA, It's done.
Yes we have some valuable data and with Novartis hopefully pursue a treatment for ards, a long way to go.
The CHF, CLBP & AGVHD treatments is where it's at.
What's everyone's expectations for the rest of the year? Any news upcoming other than OTAT? GL All
Rem-L needed Yesterday, page-2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.32 |
Change
-0.025(1.86%) |
Mkt cap ! $1.507B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.35 | $1.31 | $2.699M | 2.040M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34995 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.33 | 10374 | 2 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |